{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:49:42Z","timestamp":1753890582916,"version":"3.41.2"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI124046 R01AI126311"],"award-info":[{"award-number":["R01AI124046 R01AI126311"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Drug Discov."],"abstract":"<jats:p>The criteria for the progression of hits in the discovery of leads for human African trypanosomiasis (HAT), a neglected disease caused by the microbial eukaryote <jats:italic>Trypanosoma brucei<\/jats:italic>, are not standardized. Hits are advanced upon meeting thresholds for drug-like molecules. Following those principles, pharmacokinetics (C<jats:sub>max<\/jats:sub> and AUC<jats:sub>0\u20136h<\/jats:sub>) and anti-trypanosome characteristics predicted the arrest of <jats:italic>T. brucei<\/jats:italic> proliferation in mice by three curaxins. Unexpectedly, while CBL0137 cured HAT in a mouse model, CBL0174 and CBL0187\u2014structural analogs of CBL0137 with similar drug-like properties\u2014failed to control <jats:italic>T. brucei<\/jats:italic> division. We here propose an alternative strategy that integrates physicochemical, metabolic, pharmacokinetic, pharmacodynamic, tissue distribution, and trypanocidality parameters into calculating a score for ranking compounds in hit-to-lead campaigns. Data from our studies of curaxins support the feasibility of this goal. Serum dropped the anti-trypanosome potency of CBL0174 and CBL0187 considerably. Delayed trypanocidal concentrations (DTC<jats:sub>25<\/jats:sub> and DTC<jats:sub>90<\/jats:sub>) were used to study modes of curaxin actions in trypanosomes. Efficacy of CBL0137 in mice correlated with (i) a high AUC<jats:sub>0\u20136h<\/jats:sub>:DTC<jats:sub>90<\/jats:sub> ratio, (ii) blocking of transferrin endocytosis, and (iii) the inhibition of protein synthesis. Hydroxylation of the carbazole prevented CBL0137 from inhibiting endocytosis of transferrin. The multiparametric score \u201cCuraxin HAT lead efficacy (CHLE)\u201d score was calculated using pharmacokinetic, physicochemical, metabolic, brain exposure, and pharmacodynamic data; CBL0137 was the highest scoring hit. Complementing these observations and predictive of performance of curaxins in mice, CBL0137, but not CBL0174 or CBL0187, was trypanocidal after the exposure of trypanosomes to AUC<jats:sub>0\u20136h<\/jats:sub> amounts of the hits for 6\u00a0hours <jats:italic>in vitro<\/jats:italic>. We discuss a role for CHLE scores in ranking curaxins for anti-HAT lead discovery. The principles used to develop CHLE scores may be used to calculate new ones for other scaffolds during the discovery of leads for HAT or other infectious diseases.<\/jats:p>","DOI":"10.3389\/fddsv.2024.1430927","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T04:50:25Z","timestamp":1723697425000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiparameter ranking of carbazoles for anti-trypanosome lead discovery"],"prefix":"10.3389","volume":"4","author":[{"given":"Amrita","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Sanz-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Pollastri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Purmal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojo","family":"Mensa-Wilmot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1021\/acs.jmedchem.8b01365","article-title":"Improvement of aqueous solubility of lapatinib-derived analogues: identification of a quinolinimine lead for human african trypanosomiasis drug development","volume":"62","author":"Bachovchin","year":"2019","journal-title":"J. Med. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.pt.2018.08.006","article-title":"The long wait for a new drug for human african trypanosomiasis","volume":"34","author":"Baker","year":"2018","journal-title":"Trends Parasitol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1800181","DOI":"10.1002\/bies.201800181","article-title":"Evolution of antigenic variation in african trypanosomes: variant surface glycoprotein expression, structure, and function","volume":"40","author":"Bangs","year":"2018","journal-title":"Bioessays"},{"key":"B4","doi-asserted-by":"publisher","first-page":"13054","DOI":"10.1021\/acs.jmedchem.1c01151","article-title":"Structure-based optimization of quinazolines as cruzain and TbrCATL inhibitors","volume":"64","author":"Barbosa da Silva","year":"2021","journal-title":"J. Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1007315","DOI":"10.1371\/journal.ppat.1007315","article-title":"The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing","volume":"14","author":"Begolo","year":"2018","journal-title":"PLoS Pathog."},{"key":"B6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/tropicalmed5010023","article-title":"Phenotypic drug discovery for human african trypanosomiasis: a powerful approach","volume":"5","author":"Buckner","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"11038","DOI":"10.18632\/oncotarget.2701","article-title":"Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer","volume":"5","author":"Burkhart","year":"2014","journal-title":"Oncotarget"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.1371\/journal.pntd.0000486","article-title":"Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness","volume":"3","author":"Claes","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1128\/AAC.00044-13","article-title":"Metabolomics guides rational development of a simplified cell culture medium for drug screening against Trypanosoma brucei","volume":"57","author":"Creek","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1009866","DOI":"10.1371\/journal.ppat.1009866","article-title":"Thinking outside the blood: perspectives on tissue-resident Trypanosoma brucei","volume":"17","author":"Crilly","year":"2021","journal-title":"PLoS Pathog."},{"key":"B11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","article-title":"Fexinidazole: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"B12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-018-0327-4","article-title":"Challenges and recent progress in drug discovery for tropical diseases","volume":"559","author":"De Rycker","year":"2018","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1021\/acsmedchemlett.7b00011","article-title":"Antiparasitic lead discovery: toward optimization of a chemotype with activity against multiple protozoan parasites","volume":"8","author":"Devine","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/tropicalmed5010029","article-title":"New drugs for human african trypanosomiasis: a twenty first century success story","volume":"5","author":"Dickie","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"102209","DOI":"10.1016\/j.mib.2022.102209","article-title":"Emergence and adaptation of the cellular machinery directing antigenic variation in the African trypanosome","volume":"70","author":"Faria","year":"2022","journal-title":"Curr. Opin. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/1087057114556236","article-title":"Drug discovery for human african trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR green assay for trypanosoma brucei","volume":"20","author":"Faria","year":"2015","journal-title":"J. Biomol. Screen"},{"key":"B17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1042\/0264-6021:3420691","article-title":"Iron-dependent regulation of transferrin receptor expression in Trypanosoma brucei","volume":"342","author":"Fast","year":"1999","journal-title":"Biochem. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0006834","DOI":"10.1371\/journal.pntd.0006834","article-title":"Anilinoquinoline based inhibitors of trypanosomatid proliferation","volume":"12","author":"Ferrins","year":"2018","journal-title":"PLOS Neglected Trop. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"111409","DOI":"10.1016\/j.molbiopara.2021.111409","article-title":"The role of glycosylphosphatidylinositol phospholipase C in membrane trafficking in Trypanosoma brucei","volume":"245","author":"Garrison","year":"2021","journal-title":"Mol. Biochem. Parasitol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e01865","DOI":"10.1128\/AAC.01865-16","article-title":"Novel effects of lapatinib revealed in the african trypanosome by using hypothesis-generating proteomics and chemical biology strategies","volume":"61","author":"Guyett","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1021\/acsinfecdis.6b00077","article-title":"Glycogen synthase kinase 3\u03b2 promotes the endocytosis of transferrin in the african trypanosome","volume":"2","author":"Guyett","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/QCO.0000000000000860","article-title":"Gambiense human African trypanosomiasis: the bumpy road to elimination","volume":"35","author":"Hasker","year":"2022","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers","volume":"75","author":"Hirumi","year":"1989","journal-title":"J. Parasitol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0169-4758(94)90402-2","article-title":"Axenic culture of African trypanosome bloodstream forms","volume":"10","author":"Hirumi","year":"1994","journal-title":"Parasitol. Today."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ejmech.2016.10.024","article-title":"Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitors","volume":"124","author":"Huang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"B27","doi-asserted-by":"publisher","first-page":"828111","DOI":"10.3389\/fvets.2022.828111","article-title":"An update on african trypanocide pharmaceutics and resistance","volume":"9","author":"Kasozi","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijpharm.2008.05.001","article-title":"In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors","volume":"361","author":"Konsoula","year":"2008","journal-title":"Int. J. Pharm."},{"key":"B30","doi-asserted-by":"publisher","first-page":"18572","DOI":"10.1038\/s41598-022-22054-x","article-title":"Pseudokinase NRP1 facilitates endocytosis of transferrin in the African trypanosome","volume":"12","author":"Kumar","year":"2022","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molbiopara.2015.01.006","article-title":"25 years of African trypanosome research: from description to molecular dissection and new drug discovery","volume":"200","author":"Matthews","year":"2015","journal-title":"Mol. Biochem. Parasitol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/molpharm.120.000186","article-title":"How physiologic targets can Be distinguished from drug-binding proteins","volume":"100","author":"Mensa-Wilmot","year":"2021","journal-title":"Mol. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0063221","DOI":"10.1128\/AAC.00632-21","article-title":"Cytosolic and mitochondrial Hsp90 in cytokinesis, mitochondrial DNA replication, and drug action in trypanosoma brucei","volume":"65","author":"Meyer","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"108102","DOI":"10.1016\/j.exppara.2021.108102","article-title":"Carbohydrate metabolism in trypanosomatids: new insights revealing novel complexity, diversity and species-unique features","volume":"224","author":"Michels","year":"2021","journal-title":"Exp. Parasitol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/BJ20030469","article-title":"Rab5 and Rab11 mediate transferrin and anti-variant surface glycoprotein antibody recycling in Trypanosoma brucei","volume":"374","author":"Pal","year":"2003","journal-title":"Biochem. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"122004","DOI":"10.1016\/j.ijpharm.2022.122004","article-title":"The Caco-2 Model: modifications and enhancements to improve efficiency and predictive performance","volume":"624","author":"Panse","year":"2022","journal-title":"Int. J. Pharm."},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.coi.2021.02.007","article-title":"Genetic and immunological basis of human African trypanosomiasis","volume":"72","author":"Pays","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0007381","DOI":"10.1371\/journal.pntd.0007381","article-title":"The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis","volume":"13","author":"Pelfrene","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"641392","DOI":"10.1155\/2015\/641392","article-title":"Transferrin: endocytosis and cell signaling in parasitic Protozoa","volume":"2015","author":"Reyes-Lopez","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/molpharm.121.000430","article-title":"Physiologic targets and modes of action for CBL0137, a lead for human african trypanosomiasis drug development","volume":"102","author":"Sanz-Rodriguez","year":"2022","journal-title":"Mol. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"105302","DOI":"10.1016\/j.isci.2022.105302","article-title":"Hypothesis-generating proteome perturbation to identify NEU-4438 and acoziborole modes of action in the African Trypanosome","volume":"25","author":"Sharma","year":"2022","journal-title":"iScience"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1021\/acs.jmedchem.2c01767","article-title":"Chemical optimization of CBL0137 for human african trypanosomiasis lead drug discovery","volume":"66","author":"Singh","year":"2023","journal-title":"J. Med. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1128\/AAC.00332-10","article-title":"Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis","volume":"54","author":"Sokolova","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1042\/BJ20080167","article-title":"Glycosylphosphatidylinositol-specific phospholipase C regulates transferrin endocytosis in the African trypanosome","volume":"417","author":"Subramanya","year":"2009","journal-title":"Biochem. J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1124\/mol.116.106906","article-title":"AEE788 inhibits basal body assembly and blocks DNA replication in the african trypanosome","volume":"91","author":"Sullenberger","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"32083","DOI":"10.1038\/srep32083","article-title":"Discovery of a carbazole-derived lead drug for human African trypanosomiasis","volume":"6","author":"Thomas","year":"2016","journal-title":"Sci. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/tra.12565","article-title":"Rab11 mediates selective recycling and endocytic trafficking in Trypanosoma brucei","volume":"19","author":"Umaer","year":"2018","journal-title":"Traffic"},{"key":"B49","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jac\/dkv376","article-title":"Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei","volume":"71","author":"Wyllie","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1023\/a:1012102522787","article-title":"In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth","volume":"14","author":"Yee","year":"1997","journal-title":"Pharm. Res."}],"container-title":["Frontiers in Drug Discovery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddsv.2024.1430927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T04:50:28Z","timestamp":1723697428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddsv.2024.1430927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":50,"alternative-id":["10.3389\/fddsv.2024.1430927"],"URL":"https:\/\/doi.org\/10.3389\/fddsv.2024.1430927","relation":{},"ISSN":["2674-0338"],"issn-type":[{"type":"electronic","value":"2674-0338"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"article-number":"1430927"}}